1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Table 2:Potential markers of symptoms, related conditions, and procedural complications
Diagnosis or Procedure Category Total n = 2535 Neurosurgical n = 1881 Endovascular n = 654 P* Postop neurological complications 6.8 7.4 (140) 4.7 (31) <.05† Cranial nerve palsy (IIIrd, VIth) 6.0 7.0 (132) 2.9 (19) <.0001 Mechanical ventilation 5.0 5.6 (106) 3.1 (20) <.01† Physical or occupational therapy 5.0 6.0 (113) 2.1 (14) <.0001 Hemiplegia or hemiparesis 4.3 4.0 (76) 5.2 (34) .21† Occlusion of cerebral artery 3.8 4.2 (79) 2.8 (18) .10† Packed red blood cell transfusion 3.8 4.5 (85) 1.7 (11) <.01 Other complication/postop infection 3.8 4.5 (85) 1.5 (10) <.001† Endotracheal tube 3.5 3.9 (74) 2.3 (15) <.05† Ventriculostomy 2.9 3.4 (63) 1.7 (11) <.05† Hematoma complication 2.8 2.7 (50) 3.2 (21) .46 Postop respiratory insufficiency 2.5 2.8 (52) 1.8 (12) .19† Aphasia 2.1 2.2 (42) 1.7 (11) .70 Hydrocephalus 2.1 1.9 (36) 2.5 (16) 0.41† Gastrostomy 2.0 2.3 (44) 1.1 (7) <.05 Headache 1.6 1.5 (29) 1.7 (11) .80 Tracheostomy 1.5 1.6 (30) 1.1 (7) .34 Postop cardiac complications 0.8 0.9 (16) 0.5 (3) .32 Monocular vision loss 0.5 0.5 (10) 0.5 (3) .82 Ventriculoperitoneal shunting 0.5 0.5 (9) 0.5 (3) .95
Note:—Values are presented as % (n).
* Pearson χ 2 test used to evaluate differences between neurosurgical and endovascular groups. Significant P values are groups into 4 categories: <.05, <.01, <.001, <.0001.
† Conditions significantly (p <0.0001) more likely to occur in death cases compared with nondeaths